Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review

Aas, 2014, A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation, Front. Psychiatry, 4, 182, 10.3389/fpsyt.2013.00182

Alboni, 2014, Interleukin 18 activates MAPKs and STAT3 but not NF-kappaB in hippocampal HT-22 cells, Brain Behav. Immun., 40, 85, 10.1016/j.bbi.2014.02.015

Andrade, 2016, Anti-inflammatory strategies in the treatment of schizophrenia, Expert. Rev. Clin. Pharmacol., 9, 161, 10.1586/17512433.2016.1095086

Asevedo, 2013, Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia, J. Psychiatr. Res., 47, 1376, 10.1016/j.jpsychires.2013.05.032

Asevedo, 2014, Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia, Physiol. Behav., 129, 194, 10.1016/j.physbeh.2014.02.032

Baganz, 2013, A dialogue between the immune system and brain, spoken in the language of serotonin, ACS Chem. Neurosci., 4, 48, 10.1021/cn300186b

Barak, 1995, Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients, J. Basic Clin. Physiol. Pharmacol., 6, 61, 10.1515/JBCPP.1995.6.1.61

Barbosa, 2012, Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers, J. Affect. Disord., 137, 151, 10.1016/j.jad.2011.12.034

Bates, 2004, The d2 test of attention: construct validity and extensions in scoring techniques, J. Int. Neuropsychol. Soc.: JINS, 10, 392, 10.1017/S135561770410307X

Bauer, 2014, Inflammatory mediators of cognitive impairment in bipolar disorder, J. Psychiatr. Res., 56, 18, 10.1016/j.jpsychires.2014.04.017

Baumeister, 2016, Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-alpha, Mol. Psychiatry, 21, 642, 10.1038/mp.2015.67

Benedetti, 2016, Inflammatory cytokines influence measures of white matter integrity in bipolar disorder, J. Affect. Disord., 202, 1, 10.1016/j.jad.2016.05.047

Bezchlibnyk, 2001, Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex, J. Neurochem., 79, 826, 10.1046/j.1471-4159.2001.00628.x

Bilder, 1992, Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration, Schizophr. Bull., 18, 437, 10.1093/schbul/18.3.437

Bora, 2015, Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls, Schizophr. Bull., 41, 1095, 10.1093/schbul/sbu198

Borsini, 2015, The role of inflammatory cytokines as key modulators of neurogenesis, Trends Neurosci., 38, 145, 10.1016/j.tins.2014.12.006

Bortolato, 2015, The involvement of TNF-alpha in cognitive dysfunction associated with major depressive disorder: an opportunity for domain specific treatments, Curr. Neuropharmacol., 13, 558, 10.2174/1570159X13666150630171433

Bortolato, 2015, Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses, Neuropsychiatr. Dis. Treat., 11, 3111

Bulzacka, 2016, Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset, Schizophr. Bull., 42, 1290, 10.1093/schbul/sbw029

Chung, 2013, The link between high-sensitivity C-reactive protein and orbitofrontal cortex in euthymic bipolar disorder, Neuropsychobiology, 68, 168, 10.1159/000353613

Clerici, 2009, Cytokine polymorphisms in the pathophysiology of mood disorders, CNS Spectrums, 14, 419, 10.1017/S1092852900020393

Cochrane, 2003, Collaboration

Dargel, 2015, C-reactive protein alterations in bipolar disorder: a meta-analysis, J. Clin. Psychiatry, 76, 142, 10.4088/JCP.14r09007

Davis, 1999, The doors and people memory test: validation of norms and some new correction formulae, Br. J. Clin. Psychol., 38, 305, 10.1348/014466599162881

Dickerson, 2007, The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia, Schizophr. Res., 89, 173, 10.1016/j.schres.2006.08.015

Dickerson, 2007, C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia, Schizophr. Res., 93, 261, 10.1016/j.schres.2007.03.022

Dickerson, 2012, Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia, Schizophr. Res., 134, 83, 10.1016/j.schres.2011.10.003

Dickerson, 2013, Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder, J. Affect. Disord., 150, 456, 10.1016/j.jad.2013.04.039

Dickerson, 2014, A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors, Schizophr. Res., 156, 248, 10.1016/j.schres.2014.04.019

Doganavsargil-Baysal, 2013, Levels of TNF-alpha, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder, Hum. Psychopharmacol., 28, 160, 10.1002/hup.2301

Dubois, 2000, The FAB: a Frontal Assessment Battery at bedside, Neurology, 55, 1621, 10.1212/WNL.55.11.1621

Elwood, 1995, The California verbal learning test: psychometric characteristics and clinical application, Neuropsychol. Rev., 5, 173, 10.1007/BF02214761

Ezeoke, 2013, A systematic, quantitative review of blood autoantibodies in schizophrenia, Schizophr. Res., 150, 245, 10.1016/j.schres.2013.07.029

Felger, 2012, Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise, Front. Neuroendocrinol., 33, 315, 10.1016/j.yfrne.2012.09.003

Fernandes, 2016, C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications, Mol. Psychiatry, 21, 554, 10.1038/mp.2015.87

Fillman, 2016, Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume, Mol. Psychiatry, 21, 1090, 10.1038/mp.2015.90

Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6

Frydecka, 2014, Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands, Front. Behav. Neurosci., 8, 416, 10.3389/fnbeh.2014.00416

Frydecka, 2015, Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation, Eur. Arch. Psychiatry Clin. Neurosci., 265, 449

Frydecka, 2015, Sex differences in TGFB-beta signaling with respect to age of onset and cognitive functioning in schizophrenia, Neuropsychiatr. Dis. Treat., 11, 575

Goldsmith, 2016, A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression, Mol. Psychiatry, 21, 1696, 10.1038/mp.2016.3

Goshen, 2007, A dual role for interleukin-1 in hippocampal-dependent memory processes, Psychoneuroendocrinology, 32, 1106, 10.1016/j.psyneuen.2007.09.004

Goshen, 2008, Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression, Mol. Psychiatry, 13, 717, 10.1038/sj.mp.4002055

Greub, 2006, The validity of the letter memory test as a measure of memory malingering: robustness to coaching, Arch. Clin. Neuropsychol., 21, 249, 10.1016/j.acn.2005.12.006

Hamdani, 2015, Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels, J. Affect. Disord., 179, 161, 10.1016/j.jad.2015.03.038

Hays, 2002, Concurrent validity of the Wechsler abbreviated scale of intelligence and the Kaufman brief intelligence test among psychiatric inpatients, Psychol. Rep., 90, 355, 10.2466/pr0.2002.90.2.355

Homack, 2005, Test review: Delis-Kaplan executive function system, J. Clin. Exp. Neuropsychol., 27, 599, 10.1080/13803390490918444

Hope, 2015, Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls, Schizophr. Res., 165, 188, 10.1016/j.schres.2015.04.004

Hori, 2016, Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy, World J. Biol. Psychiatry, 1

Hudson, 2016, Meta-analysis of cytokine and chemokine genes in schizophrenia, Clin. Schizophr. Relat. Psychoses

Ibrahim, 2013, A systematic review of studies of depression prevalence in university students, J. Psychiatr. Res., 47, 391, 10.1016/j.jpsychires.2012.11.015

Jersild, 1927, Mental set and shift, Arch. Psychol., 14, 81

Johnsen, 2016, The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis, BMC Psychiatry, 16, 60, 10.1186/s12888-016-0769-x

Joseph, 2015, Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups, Schizophr. Res., 10.1016/j.schres.2015.08.019

Kaneda, 2007, Brief assessment of cognition in schizophrenia: validation of the Japanese version, Psychiatry Clin. Neurosci., 61, 602, 10.1111/j.1440-1819.2007.01725.x

Karpinski, 2016, Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder, Brain Behav. Immun., 54, 194, 10.1016/j.bbi.2016.02.005

Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261

Kessler, 1988, Manual Demenz test - Wrotproduktion (“Supermarktaufgabe”), Dementznornmen., 10

Kinney, 2009, Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?, Schizophr. Bull., 35, 582, 10.1093/schbul/sbp023

Krikorian, 1994, Tower of London procedure: a standard method and developmental data, J. Clin. Exp. Neuropsychol., 16, 840, 10.1080/01688639408402697

Kroken, 2014, A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation, Front. Psychiatry, 5, 11, 10.3389/fpsyt.2014.00011

Kurtz, 2009, A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state, Neuropsychology, 23, 551, 10.1037/a0016277

Laskaris, 2016, Microglial activation and progressive brain changes in schizophrenia, Br. J. Pharmacol., 173, 666, 10.1111/bph.13364

Li, 2008, Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior, Life Sci., 82, 934, 10.1016/j.lfs.2008.02.010

Liu, 2011, Cross-cultural comparisons on Wisconsin card sorting test performance in euthymic patients with bipolar disorder, Psychiatry Res., 189, 469, 10.1016/j.psychres.2011.05.038

Lotrich, 2014, The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder, Int. J. Geriatr. Psychiatry, 29, 635, 10.1002/gps.4048

Lv, 2015, Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition, Psychopharmacology, 232, 165, 10.1007/s00213-014-3650-y

Malek-Ahmadi, 2011, The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment, Dement. Geriatr. Cogn. Disord., 32, 235, 10.1159/000334525

Marangoni, 2016, The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies, J. Affect. Disord., 193, 165, 10.1016/j.jad.2015.12.055

Martinez-Cengotitabengoa, 2012, Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes, Schizophr. Res., 137, 66, 10.1016/j.schres.2012.03.004

McAfoose, 2009, Evidence for a cytokine model of cognitive function, Neurosci. Biobehav. Rev., 33, 355, 10.1016/j.neubiorev.2008.10.005

McClay, 2011, Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia, Neuropsychopharmacology, 36, 616, 10.1038/npp.2010.193

Metcalf, 2017, Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study, Brain Behav. Immun., 59, 253, 10.1016/j.bbi.2016.09.008

Micoulaud-Franchi, 2015, Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia, Schizophr. Res., 165, 94, 10.1016/j.schres.2015.03.018

Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013

Miller, 2013, Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 73, 993, 10.1016/j.biopsych.2012.09.007

Misiak, 2017, Toward a unified theory of childhood trauma and psychosis: a comprehensive review of epidemiological, clinical, neuropsychological and biological findings, Neurosci. Biobehav. Rev., 75, 393, 10.1016/j.neubiorev.2017.02.015

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med., 6, 10.1371/journal.pmed.1000097

Moller, 2003, Bipolar disorder and schizophrenia: distinct illnesses or a continuum?, J. Clin. Psychiatry, 64, 23

Moustafa, 2016, Cognitive function in schizophrenia: conflicting findings and future directions, Rev. Neurosci., 27, 435, 10.1515/revneuro-2015-0060

Muller, 2015, The role of inflammation in schizophrenia, Front. Neurosci., 9, 372, 10.3389/fnins.2015.00372

Munkholm, 2013, Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis, J. Psychiatr. Res., 47, 1119, 10.1016/j.jpsychires.2013.05.018

Najjar, 2015, Neuroinflammation and white matter pathology in schizophrenia: systematic review, Schizophr. Res., 161, 102, 10.1016/j.schres.2014.04.041

Nelson, 1978, Dementia: the estimation of premorbid intelligence levels using the new adult reading test, Cortex, 14, 234, 10.1016/S0010-9452(78)80049-5

Nuechterlein, 2008, The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity, Am. J. Psychiatry, 165, 203, 10.1176/appi.ajp.2007.07010042

Pearlman, 2014, Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder, Schizophr. Res., 157, 249, 10.1016/j.schres.2014.05.001

Penner, 2012, The Stroop task: comparison between the original paradigm and computerized versions in children and adults, Clin. Neuropsychol., 26, 1142, 10.1080/13854046.2012.713513

Potvin, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol. Psychiatry, 63, 801, 10.1016/j.biopsych.2007.09.024

Randolph, 1998, The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity, J. Clin. Exp. Neuropsychol., 20, 310, 10.1076/jcen.20.3.310.823

Rao, 2010, Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients, Mol. Psychiatry, 15, 384, 10.1038/mp.2009.47

Rao, 2013, Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients, Schizophr. Res., 147, 24, 10.1016/j.schres.2013.02.017

Rasmusson, 1995, Stability of performance on the Hopkins verbal learning test, Arch. Clin. Neuropsychol., 10, 21, 10.1093/arclin/10.1.21

Reitan, 1955, The relation of the trail making test to organic brain damage, J. Consult. Psychol., 19, 393, 10.1037/h0044509

Rey, 1964

Ribeiro-Santos, 2014, Evidence for an immune role on cognition in schizophrenia: a systematic review, Curr. Neuropharmacol., 12, 273, 10.2174/1570159X1203140511160832

Rogers, 1995, Costs of a predictable switch between simple cognitive tasks, J. Exp. Psychol. General, 124, 207, 10.1037/0096-3445.124.2.207

Rosenblat, 2015, Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications, J. Affect. Disord., 188, 149, 10.1016/j.jad.2015.08.058

Salthouse, 1991, Effects of adult age on structural and operational capacities in working memory, Psychol. Aging, 6, 118, 10.1037/0882-7974.6.1.118

Sasayama, 2013, Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder, J. Psychiatr. Res., 47, 401, 10.1016/j.jpsychires.2012.12.001

Seabra, 2009, Validity evidence for the reading competence test of words and non-words, Sp. J. Psychol., 12, 788, 10.1017/S1138741600002158

Shao, 2014, What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults, Front. Psychol., 5, 772, 10.3389/fpsyg.2014.00772

Shmukler, 2015, Long-term trajectories of cognitive deficits in schizophrenia: a critical overview, Eur. Psychiatry, 30, 1002, 10.1016/j.eurpsy.2015.08.005

Stefanopoulou, 2009, Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis, Int. Rev. Psychiatry, 21, 336, 10.1080/09540260902962149

Tan, 2015, Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia, Schizophr. Res., 169, 16, 10.1016/j.schres.2015.10.038

Thompson-Schill, 1997, Role of left inferior prefrontal cortex in retrieval of semantic knowledge: a reevaluation, Proc. Natl. Acad. Sci. U. S. A., 94, 14792, 10.1073/pnas.94.26.14792

Tourjman, 2013, Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis, Schizophr. Res., 151, 43, 10.1016/j.schres.2013.10.011

Trepanier, 2016, Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review, Mol. Psychiatry, 21, 1009, 10.1038/mp.2016.90

Vuksan-Cusa, 2010, C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia, Psychiatr. Danub., 22, 275

Vuksan-Cusa, 2013, Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia, Nord. J. Psychiatry, 67, 320, 10.3109/08039488.2012.745601

Wallwork, 2012, Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia, Schizophr. Res., 137, 246, 10.1016/j.schres.2012.01.031

Wang, 1998, Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism, Neurochem. Int., 33, 143, 10.1016/S0197-0186(98)00016-3

Wechsler, 1997

Wechsler, 1997

Whitney, 2010, Validity of the Wechsler Test of Adult Reading (WTAR): effort considered in a clinical sample of U.S. military veterans, Appl. Neuropsychol., 17, 196, 10.1080/09084282.2010.499787

Windgassen, 2011, C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians, Postgrad. Med., 123, 114, 10.3810/pgm.2011.01.2252

Wu, 2016, Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia, J. Psychiatr. Res., 76, 9, 10.1016/j.jpsychires.2016.01.013

Xiu, 2014, Decreased interleukin-10 serum levels in first-episode drug-naive schizophrenia: relationship to psychopathology, Schizophr. Res., 156, 9, 10.1016/j.schres.2014.03.024

Xiu, 2016, Contribution of IL-10 and its −592A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia, Brain Behav. Immun., 57, 116, 10.1016/j.bbi.2016.03.005

Yntema, 1963, Keeping track of several things at once, Hum. Factors, 5, 7, 10.1177/001872086300500102

Zalcman, 1994, Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6, Brain Res., 643, 40, 10.1016/0006-8993(94)90006-X

Zhang, 2013, Interleukin 18 and cognitive impairment in first episode and drug naive schizophrenia versus healthy controls, Brain Behav. Immun., 32, 105, 10.1016/j.bbi.2013.03.001

Zhang, 2016, Interaction of BDNF with cytokines in chronic schizophrenia, Brain Behav. Immun., 51, 169, 10.1016/j.bbi.2015.09.014